Do we need to MEND the MELD?

Liver Transplantation

Volumn 13, Issue 4, 2007, Pages 486-487

  Gish, Robert G ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EDITORIAL; GRAFT SURVIVAL; HEALTH SURVEY; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MATHEMATICAL MODEL; MORTALITY; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; STANDARDIZATION;

HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 34247229189     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21040     Document Type: Editorial

References (17)

1. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858.
2. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1-7.
3. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
4. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
5. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
6. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004;10:995-1000.
7. Bzowej NH, Huilgol VR, Sebanc H, Bonacini M, Rabkin J Doo, et al. MELD underestimated unless enzymatic creatinine used. J Hepatol 2004;40(Suppl 2):40.
8. Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007; 13: 523-529.
9. Dorwart WV. Bilirubin interference in kinetic creatinine determination. Clin Chem 1979;25:196-197.
10. Bowers LD, Wong ET. Kinetic serum creatinine assays. II. A critical evaluation and review. Clin Chem 1980;26:555-561.
11. Gerhardt G, Davitt C, Chan DW. Serum separator tube problems in Hitachi 736/737 analyzers. Clin Chem 1989; 36:1554.
12. Delanghe JR, Louagie HK, De Buyzere ML, Leroux-Roels GG. Glomerular filtration rate and creatinine production in adult icteric patients. Clin Chim Acta 1994;224:33-44.
13. Boot S, LaRoche N, Legg EF. Elimination of bilirubin interference in creatinine assays by routine techniques: comparisons with a high performance liquid chromatography method. Ann Clin Biochem 1994;31:262-266.
14. Blijenberg BG, Zwang L, van Tilborg M. New approaches with Chem-1 creatinine determination. Eur J Clin Chem Clin Biochem 1993:31:29-33.
15. Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005;129:297-304.
16. Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem 1991;37: 695-700.
17. Weisner R, Lake JR, Freeman RB, Gish RG. Model for End-Stage Liver Disease (MELD) exception guidelines. Liver Transpl 2006; 12(Suppl 3):S85-S87.